Focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.
Appello Pharmaceuticals, Inc.
01 Introduction
Focusing on innovative early-stage drugs for patients living with disorders of the central nervous system.
